Research

Problem:

Currently, there is an urgent need for simple, rapid, sideline or bedside assays assessing TIA, risk of ischemic stroke, severity of concussions & risk of posttraumatic epilepsy

 

Potential users of assays:

 

  • Emergency Departments

  • Trauma centers

  • Military and civilian hospitals

  • Neurologists, surgeons, and anesthesiologists

  • Sport clubs and schools

  • Medical offices 

  • Out-patient services

  • Insurance companies

Solutions:

 

Point-of-care (POC) tests assessing TIA, risk of ischemic stroke, severity of concussions & risk of posttraumatic epilepsy

 

  • Sideline or bedside detection (stadium, emergency room, ambulance, combat theater)

  • User-friendly and affordable 

  • No additional Lab equipment & supplies

  • Results within 5 minutes, with color detection via mobile applications (IOS, Android, W8)

  • Safety of personal data storage in the Cloud with restricted access

Procedure
  • Blood sampling from digit (about 20 μl)

 

 

 

 

  • About 20-second reaction time

 

 

 

 

  • Photographing the test strip

 

 

 

 

  • Results in <5 minutes

NR2 Antibody Test Kit
For in vitro quantitative determination of antibodies to NR2 subunit of NMDA receptors in serum

 

Price: request

 

 

ELISA KIT "NR2 antibody test", for research use only

NR2 antibody test 

Адрес/Address

Улан-Удэ:

пр. 50-лет Октября, 13, Улан-Удэ, Россия, 670034

Москва:

ул. Большой Бульвар, 42 стр. 1, офис 357, Москва, Россия, 143026

8-495-280-8114

 

США:

160 Клэйрмонт Авенью, сьют 200, Декейтер, Джорджия, США, 30030.

Ulan-Ude:

pr. 50 let Oktyabrya, 13, Ulan-Ude, Russia, 670034

Moscow:

Bolshoy bulvar, 42 b. 1, office 357, Moscow, Russia, 143026

 

USA:

160 Clairemont Ave, Suite 200, Decatur, GA, 30030, USA

  • Wix Facebook page
  • Twitter Classic
  • Vkontakte App Icon

Карта/Map

Исследования осуществляются ООО "ДРД" при грантовой поддержке Фонда "Сколково"

© 2014 DRD Diagnostic Reagents Devices